DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2023
    • Call for Papers
    • Sponsor and Exhibit
    • New Researcher Network
    • Conference Logistics
    • Media Partners
  • Archive
    • Conference Papers Archive
    • DDL2022
      • APS Workshop
      • Conference Papers
      • DDL2022 Programme
      • DDL2022 Speakers
      • DDL2022 Sponsors
      • DDL2022 Photo Album
    • DDL2021
      • Conference Papers
      • DDL2021 Programme
      • DDL2021 Speakers
      • DDL2021 Sponsors
    • DDL2020
      • Conference Papers
      • Speakers and Lecture Recordings
      • Sponsors
    • DDL2019
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2019 Photo Album
    • DDL2018
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2018 Photo Album
    • DDL2017
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2017 Photo Album
    • DDL2016
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2015
      • Conference Papers
    • Previous Years
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • Scientific Advisors
  • Associated Events
    • EPSRC CDT in Aerosol Science Annual Conference 2023
    • ERS International Congress 2023
    • ISAM Congress 2023
    • RDD Europe 2023
  • Contact
  • The Aerosol Society logo
Sanket Pandya :

Sanket Pandya

Zydus Research Centre (ZRC)

Paper: Dry Powder Inhalation of Glucagon-like Peptide-1 for Management of Type-2 Diabetes Mellitus

Sanket has pursued his Ph. D. in Pharmaceutical Sciences from CSIR-Central Drug Research Institute (CDRI), Lucknow (India). Currently, he works at Zydus Research Centre (ZRC), Ahmedabad (India) in the department of Novel Drug Delivery Systems (NDDS). Sanket obtained his M.S. (Pharm) in Pharmaceutics from National Institute of Pharmaceutical Education and Research (NIPER). Before joining CSIR-CDRI, he was associated with Novartis (Sandoz Private Limited, Mumbai) for a brief period where he worked in Galenicals (F&D) department at Sandoz Development Centre (SDC).
His research is majorly focused on developing inhalation, intra-nasal and injectable dosage forms. His key interests are into areas of pharmaceutical technology including particle engineering, characterization and optimization of formulation, physicochemical and biological evaluation of novel formulations for pulmonary as well as parenteral delivery. Sanket has commendable experience on developing peptide based drug delivery systems for immediate as well as sustained release. His doctoral thesis focuses on developing and evaluating (in vitro and in vivo) dry powder inhalation of an anti-diabetic peptide for management of type 2 diabetes mellitus. He has also worked on inhalable polymeric micro-particulate drug delivery systems for pulmonary tuberculosis and is quite proficient with techniques such as spray-drying, spray-freeze drying and super-critical fluid (SCF) technology for the preparation of inhalable particles. Sanket is acquainted with using Design of Experiments (QbD) for formula and process optimization; he also has experience on developing an in-house inhalation (DPI) device and evaluating its design using computational fluid dynamics. Sanket has published >10 peer reviewed journal articles and 1 book chapter.

Photos of Sanket Pandya

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2023 Drug Delivery to the Lungs Website design: definingdesign.co.uk